Atlas Trials

Zanubrutinib for HLH

Clinical trial NCT05320575 · COMPLETED

Trial details

NCT number
NCT05320575
Sponsor
Beijing Friendship Hospital
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HLH
Start date
2022-02-01
Primary completion
2023-08-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.